Malignant Digestive System Neoplasm — Trials

Malignant Digestive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

19,110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,263
Recruiting: 2,366
Ph III recruiting: 290
Growth YoY: +12.2%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 28.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2,003)

clinicaltrialsPublishedShowing 401–450 of 2,379 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02528643	A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma	completed	Phase 2	165	Astellas Pharma Global Development, Inc.INDUSTRY	9	Dec 6, 2024	clinicaltrials
NCT03009461	Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis	completed	Phase 2	64	Peking UniversityOTHER	1	Dec 4, 2024	clinicaltrials